论文部分内容阅读
Background:To investigate clinical application value of acoustic radiation force impulse(ARFI)in the assessment of liver fibrosis.
The clinical value of noninvasive assessment with acoustic radiation force impulse imaging for liver
【摘 要】
：
Background:To investigate clinical application value of acoustic radiation force impulse(ARFI)in the assessment of liver fibrosis.
【机 构】
：
Graduate School of Guangxi Medical University the
【出 处】
：
2014年APASL专题会议暨第四届乙型病毒性肝炎专题会议
【发表日期】
：
2014年4期
其他文献
Background:To identify the impact of concomitant nonalcoholic fatty liver disease(NAFLD) on the development of hepatic fibrosis in patients with chronic hepatitis B(CHB).
会议
Background:Details in change of fibrosis structure in progressive cirrhosis is still unavailable.Taking advantage of qFibrosis tool,the present study aims to address this issue for understanding the p
会议
COMPARATIVE STUDY OF TELBIVUDINE AND PEGYLATED INTERFERON α-2a OPTIMIZATION THERAPY FOR E ANTIGEN-PO
Background:Aim To observe and compare the efficacy of telbivudine and pegalated interferon α-2a optimized therapy for E antigen-positive chronic hepatitis B patients.
会议
Low prevalence of Hepatitis B virus infection in patients with autoimmune diseases in a Chinese pati
Background:Hepatitis B is a very common communicable disease in China but the prevalence of hepatitis B virus(HBV) infection in patients with autoimmune diseases is unknown.We retrospectively investig
会议
The effect of complemental Ganshuang granule for improving liver fibrosis markers in patients with c
Background:To observe the ability of Ganshuang granules to improve markers of liver fibrosis when provided as supplemental therapy in patients with chronic hepatitis B(CHB) who achieved complete virol
会议
A NOVEL IMMUNOTHERAPY APPROACH WITH MULTIPLE TUMOR ANTIGENS ACTIVATED AUTOLOGOUS T CELLS IN HBV RELA
Background:Hepatocellular carcinoma(HCC) in China frequently occurs in the patients with chronic hepatitis B virus(HBV) infection.Here we present a novel approach(Smart T) of adoptive immunotherapy to
会议
ESTABLISHMENT AND VALIDATION OF ALPH-Q SCORE TO PREDICT MORTALITY RISK IN PATIENTS WITH ACUTE-ON-CHR
Background:There are no strong and powerful models in predicting the outcome of acute-on-chronic hepatitis B liver failure(ACHBLF).Here,we aimed to establish and validate a new prognostic score,named
会议
The diagnostic evaluation to the noninvasive diagnostic of HBV-related cirrhosis with the lantent cl
Background:There are many ways of diagnosis for the HBV-relative cirrhosis,especially,the noninvasive diagnosis,which had been widely used.Before these tests are applied to the clinic,which should be
会议
Background:A therapeutic vaccine for chronic hepatitis B that is individualised to contain only peptides specific to each patients HLA class I genotype should have the lowest risk of side effects,and
会议
The lower replication capacity of hepatitis B virus genotype C2 than B2 isolates correlates with low
Background:Infection by hepatitis B virus(HBV)genotype C leads to delayed HBeAg seroconversion than genotype B infection,which increases the risk for liver cancer.Our previous transfection experiments
会议